300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Photography
Google
Construction
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Cryptocurrency
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Sports
Education
Automotive
Wellness
eSports
Biotechnology
Legal
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Social
Medical
Theatre
Infrastructure
Climate
LGBT
Beauty
Fashion
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Publishing
Art
Mobile Apps
Wine and Spirits
Real Estate
Sporting Goods
Manufacturing
Social Media
FinTech
Finance
Financial Services
Digital Media
Franchise
Non Profit
Internet
Android
Mobile Advertising
Proptech
Enterprise
Impact
Community
Sustainability
Hardware
Media (Entertainment)
Biotech
Transportation
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Japan
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Oman
Puerto Rico
Poland
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Morocco
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Ireland
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Bangladesh
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Estonia
Bahamas
Belize
Italy
Belarus
Finland
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Mirai Creation Investment

VC Fund

Mirai Creation Investment is a VC fund focused on Medical and Biotechnology. Mirai Creation Investment

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Mirai Creation Investment invests in

MedicalBiotechnology

Stages Mirai Creation Investment invests in

Series B

Countries Mirai Creation Investment invests in

Japan

Investment Focus

Industry

  • Medical 1 (50%)
  • Biotechnology 1 (50%)

Investments

CompanyDescriptionRoundLinks
Metagen Therapeutics Metagen Therapeutics
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. $15.7M / Series B / Sep 08, 2025
Metagen Therapeutics Metagen Therapeutics
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. $15.7M / Series B / Sep 08, 2025

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Photography
Google
Construction
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Cryptocurrency
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Sports
Education
Automotive
Wellness
eSports
Biotechnology
Legal
Software
Renewable Energy
Crowdfunding
Venture Capital
Recruiting
Web3
Social
Medical
Theatre
Infrastructure
Climate
LGBT
Beauty
Fashion
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Publishing
Art
Mobile Apps
Wine and Spirits
Real Estate
Sporting Goods
Manufacturing
Social Media
FinTech
Finance
Financial Services
Digital Media
Franchise
Non Profit
Internet
Android
Mobile Advertising
Proptech
Enterprise
Impact
Community
Sustainability
Hardware
Media (Entertainment)
Biotech
Transportation
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Japan
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Romania
Zambia
Oman
Puerto Rico
Poland
Colombia
Cameroon
Guernsey
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Morocco
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Ireland
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Bangladesh
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bolivia
Bahrain
Estonia
Bahamas
Belize
Italy
Belarus
Finland
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Mirai Creation Investment invest in?

Mirai Creation Investment invests primarily in Medical and Biotechnology startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Mirai Creation Investment last invest?

The most recent investment recorded for Mirai Creation Investment closed in Sep 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Mirai Creation Investment Find emails